Freeline is a clinical-stage biotechnology company focused on developing transformative gene therapies for people with inherited systemic debilitating diseases. Headquartered in the UK, NASDAQ quoted and operating in both Germany and the US, Freeline has strong ambitions for continued growth within both established and new territories. https://www.freeline.life/